Logo image of 1EW.MI

EDWARDS LIFESCIENCES CORP (1EW.MI) Stock Fundamental Analysis

BIT:1EW - Euronext Milan - US28176E1082 - Common Stock - Currency: EUR

66.48  +3.57 (+5.67%)

Fundamental Rating

7

1EW gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. 1EW has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1EW is quite expensive at the moment. It does show a decent growth rate. This makes 1EW very considerable for quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

1EW had positive earnings in the past year.
In the past year 1EW had a positive cash flow from operations.
1EW had positive earnings in each of the past 5 years.
1EW had a positive operating cash flow in each of the past 5 years.
1EW.MI Yearly Net Income VS EBIT VS OCF VS FCF1EW.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

1.2 Ratios

The Return On Assets of 1EW (32.06%) is better than 98.08% of its industry peers.
Looking at the Return On Equity, with a value of 43.57%, 1EW belongs to the top of the industry, outperforming 96.15% of the companies in the same industry.
1EW has a better Return On Invested Capital (12.27%) than 90.38% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1EW is significantly above the industry average of 7.96%.
The 3 year average ROIC (20.11%) for 1EW is well above the current ROIC(12.27%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 32.06%
ROE 43.57%
ROIC 12.27%
ROA(3y)17%
ROA(5y)15.7%
ROE(3y)24.35%
ROE(5y)23.26%
ROIC(3y)20.11%
ROIC(5y)19.51%
1EW.MI Yearly ROA, ROE, ROIC1EW.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 73.98%, 1EW belongs to the best of the industry, outperforming 98.08% of the companies in the same industry.
In the last couple of years the Profit Margin of 1EW has grown nicely.
The Operating Margin of 1EW (27.73%) is better than 96.15% of its industry peers.
1EW's Operating Margin has been stable in the last couple of years.
1EW has a better Gross Margin (78.63%) than 80.77% of its industry peers.
In the last couple of years the Gross Margin of 1EW has remained more or less at the same level.
Industry RankSector Rank
OM 27.73%
PM (TTM) 73.98%
GM 78.63%
OM growth 3Y-0.54%
OM growth 5Y0.18%
PM growth 3Y7.55%
PM growth 5Y3.78%
GM growth 3Y0.73%
GM growth 5Y0.6%
1EW.MI Yearly Profit, Operating, Gross Margins1EW.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1EW is creating value.
The number of shares outstanding for 1EW has been reduced compared to 1 year ago.
Compared to 5 years ago, 1EW has less shares outstanding
1EW has a better debt/assets ratio than last year.
1EW.MI Yearly Shares Outstanding1EW.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
1EW.MI Yearly Total Debt VS Total Assets1EW.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 10.48 indicates that 1EW is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 10.48, 1EW belongs to the top of the industry, outperforming 98.08% of the companies in the same industry.
1EW has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.25, 1EW belongs to the top of the industry, outperforming 94.23% of the companies in the same industry.
1EW has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.06, 1EW belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 1.25
Altman-Z 10.48
ROIC/WACC1.39
WACC8.85%
1EW.MI Yearly LT Debt VS Equity VS FCF1EW.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.3 Liquidity

1EW has a Current Ratio of 3.46. This indicates that 1EW is financially healthy and has no problem in meeting its short term obligations.
1EW has a better Current ratio (3.46) than 78.85% of its industry peers.
1EW has a Quick Ratio of 2.89. This indicates that 1EW is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.89, 1EW belongs to the top of the industry, outperforming 86.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.46
Quick Ratio 2.89
1EW.MI Yearly Current Assets VS Current Liabilites1EW.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.37% over the past year.
1EW shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.49% yearly.
The Revenue has decreased by -3.40% in the past year.
Measured over the past years, 1EW shows a quite strong growth in Revenue. The Revenue has been growing by 10.03% on average per year.
EPS 1Y (TTM)6.37%
EPS 3Y20.97%
EPS 5Y15.49%
EPS Q2Q%13.56%
Revenue 1Y (TTM)-3.4%
Revenue growth 3Y11.04%
Revenue growth 5Y10.03%
Sales Q2Q%-8.54%

3.2 Future

1EW is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.09% yearly.
The Revenue is expected to grow by 9.40% on average over the next years. This is quite good.
EPS Next Y0.74%
EPS Next 2Y-1.25%
EPS Next 3Y3.56%
EPS Next 5Y11.09%
Revenue Next Year-1.97%
Revenue Next 2Y-0.18%
Revenue Next 3Y3.02%
Revenue Next 5Y9.4%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1EW.MI Yearly Revenue VS Estimates1EW.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
1EW.MI Yearly EPS VS Estimates1EW.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

1EW is valuated quite expensively with a Price/Earnings ratio of 26.07.
73.08% of the companies in the same industry are more expensive than 1EW, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.35. 1EW is around the same levels.
With a Price/Forward Earnings ratio of 27.60, 1EW can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as 1EW.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, 1EW is valued a bit more expensive.
Industry RankSector Rank
PE 26.07
Fwd PE 27.6
1EW.MI Price Earnings VS Forward Price Earnings1EW.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1EW.
1EW's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 86.16
EV/EBITDA 23.48
1EW.MI Per share data1EW.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1EW does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of 1EW may justify a higher PE ratio.
PEG (NY)35.04
PEG (5Y)1.68
EPS Next 2Y-1.25%
EPS Next 3Y3.56%

More info and screens

0

5. Dividend

5.1 Amount

1EW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EDWARDS LIFESCIENCES CORP

BIT:1EW (3/5/2025, 7:00:00 PM)

66.48

+3.57 (+5.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)04-23 2025-04-23/amc
Inst Owners88.15%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap39.21B
Analysts73.17
Price Target71.41 (7.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.26%
Min EPS beat(2)-2.08%
Max EPS beat(2)1.57%
EPS beat(4)1
Avg EPS beat(4)-0.84%
Min EPS beat(4)-2.52%
Max EPS beat(4)1.57%
EPS beat(8)2
Avg EPS beat(8)-0.87%
EPS beat(12)3
Avg EPS beat(12)-2.04%
EPS beat(16)5
Avg EPS beat(16)-0.79%
Revenue beat(2)0
Avg Revenue beat(2)-8.94%
Min Revenue beat(2)-13.79%
Max Revenue beat(2)-4.1%
Revenue beat(4)0
Avg Revenue beat(4)-8.73%
Min Revenue beat(4)-16.65%
Max Revenue beat(4)-0.38%
Revenue beat(8)1
Avg Revenue beat(8)-4.84%
Revenue beat(12)1
Avg Revenue beat(12)-4.41%
Revenue beat(16)3
Avg Revenue beat(16)-3.34%
PT rev (1m)-11.33%
PT rev (3m)-11.33%
EPS NQ rev (1m)-22.04%
EPS NQ rev (3m)-22.04%
EPS NY rev (1m)-8.4%
EPS NY rev (3m)-8.4%
Revenue NQ rev (1m)-17.79%
Revenue NQ rev (3m)-17.79%
Revenue NY rev (1m)-9.7%
Revenue NY rev (3m)-9.7%
Valuation
Industry RankSector Rank
PE 26.07
Fwd PE 27.6
P/S 7.31
P/FCF 86.16
P/OCF 50.94
P/B 4.3
P/tB 5.88
EV/EBITDA 23.48
EPS(TTM)2.55
EY3.84%
EPS(NY)2.41
Fwd EY3.62%
FCF(TTM)0.77
FCFY1.16%
OCF(TTM)1.3
OCFY1.96%
SpS9.1
BVpS15.45
TBVpS11.3
PEG (NY)35.04
PEG (5Y)1.68
Profitability
Industry RankSector Rank
ROA 32.06%
ROE 43.57%
ROCE 14.14%
ROIC 12.27%
ROICexc 20.57%
ROICexgc 33.67%
OM 27.73%
PM (TTM) 73.98%
GM 78.63%
FCFM 8.48%
ROA(3y)17%
ROA(5y)15.7%
ROE(3y)24.35%
ROE(5y)23.26%
ROIC(3y)20.11%
ROIC(5y)19.51%
ROICexc(3y)24.76%
ROICexc(5y)24.76%
ROICexgc(3y)32.94%
ROICexgc(5y)34.79%
ROCE(3y)23.16%
ROCE(5y)22.47%
ROICexcg growth 3Y-1.5%
ROICexcg growth 5Y-7.31%
ROICexc growth 3Y0.66%
ROICexc growth 5Y-2.73%
OM growth 3Y-0.54%
OM growth 5Y0.18%
PM growth 3Y7.55%
PM growth 5Y3.78%
GM growth 3Y0.73%
GM growth 5Y0.6%
F-Score7
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 1.25
Debt/EBITDA 0.35
Cap/Depr 220.76%
Cap/Sales 5.86%
Interest Coverage 250
Cash Conversion 47.21%
Profit Quality 11.46%
Current Ratio 3.46
Quick Ratio 2.89
Altman-Z 10.48
F-Score7
WACC8.85%
ROIC/WACC1.39
Cap/Depr(3y)206.04%
Cap/Depr(5y)261.97%
Cap/Sales(3y)5.22%
Cap/Sales(5y)6.27%
Profit Quality(3y)66.94%
Profit Quality(5y)73.09%
High Growth Momentum
Growth
EPS 1Y (TTM)6.37%
EPS 3Y20.97%
EPS 5Y15.49%
EPS Q2Q%13.56%
EPS Next Y0.74%
EPS Next 2Y-1.25%
EPS Next 3Y3.56%
EPS Next 5Y11.09%
Revenue 1Y (TTM)-3.4%
Revenue growth 3Y11.04%
Revenue growth 5Y10.03%
Sales Q2Q%-8.54%
Revenue Next Year-1.97%
Revenue Next 2Y-0.18%
Revenue Next 3Y3.02%
Revenue Next 5Y9.4%
EBIT growth 1Y-12.15%
EBIT growth 3Y10.43%
EBIT growth 5Y10.23%
EBIT Next Year2.29%
EBIT Next 3Y5.22%
EBIT Next 5Y11.42%
FCF growth 1Y-54.13%
FCF growth 3Y-0.91%
FCF growth 5Y-1.68%
OCF growth 1Y-38.4%
OCF growth 3Y-5.29%
OCF growth 5Y-0.68%